Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Atherosclerotic Cardiovascular Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00653835
What this trial is testing

Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435)

Who this might be right for
HypercholesterolaemiaAtherosclerosis
Organon and Co 153
Not applicableLooking for participantsNCT07182955
What this trial is testing

Determinants of Cardiorespiratory Fitness and Effects of HIIT in Patients With ANOCA Obstructive Coronary Artery Disease(ANOCA)

Who this might be right for
MINOCAShortness of BreathAtherosclerotic Heart Disease of Native Coronary Artery
University of Virginia 25
Not applicableLooking for participantsNCT06794684
What this trial is testing

PRogression of Atheroma Evaluated by CT Angiography and IntraCoronary Imaging tEchniques

Who this might be right for
Coronary Arterial Disease (CAD)Coronary Arteriosclerosis
Ruijin Hospital 50,000
Not applicableStudy completedNCT04753372
What this trial is testing

Rivaroxaban Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk

Who this might be right for
Coronary Artery Disease (CAD)Peripheral Arterial Disease (PAD)
Maatschap Cardiologie Zwolle 645
Not applicableStudy completedNCT05974345
What this trial is testing

In Silico Study Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Patients With Established Cardiovascular Disease

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 204,691
Not applicableLooking for participantsNCT05897645
What this trial is testing

High-resolution Magnetic Resonance Imaging of Intracranial Atherosclerotic Plaques in Ischemic Stroke

Who this might be right for
StrokeIntracranial AtherosclerosisHigh Resolution Magnetic Resonance Imaging
General Hospital of Shenyang Military Region 2,110
Large-scale testing (Phase 3)Active Not RecruitingNCT05030428
What this trial is testing

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 17,004
Not applicableStudy completedNCT03942744
What this trial is testing

The Effect of High-flux Hemodialysis and On-line Hemodiafiltration on Endothelial Function.

Who this might be right for
Chronic Kidney Disease Requiring Chronic Dialysis
Maimónides Biomedical Research Institute of Córdoba 88
Not applicableUnknownNCT02176941
What this trial is testing

Telomeres and Arterial Aging

Who this might be right for
Atherosclerotic Disease
Central Hospital, Nancy, France 340
Large-scale testing (Phase 3)Study completedNCT02104817
What this trial is testing

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia

Who this might be right for
Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
AstraZeneca 13,078
Large-scale testing (Phase 3)Not Yet RecruitingNCT07242599
What this trial is testing

Ongericimab Injection Reducing Recurrence of Ischemic Stroke

Who this might be right for
Ischemic Cerebral Infarction
Beijing Tiantan Hospital 4,810
Testing effectiveness (Phase 2)Study completedNCT04992065
What this trial is testing

A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novo Nordisk A/S 267
Early research (Phase 1)Study completedNCT01554800
What this trial is testing

Effect of ACP-501 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Subjects With Coronary Artery Disease

Who this might be right for
Coronary Artery DiseaseAtherosclerosis
MedImmune LLC 16
Not applicableLooking for participantsNCT07594392
What this trial is testing

Clinical Assessment and Targeted Imaging to Characterize High-Risk Atherosclerotic Cardiovascular Disease of Survivors in SJLIFE

Who this might be right for
Atherosclerotic Cardiovascular Disease
St. Jude Children's Research Hospital 650
Not applicableLooking for participantsNCT03291652
What this trial is testing

Morphology of Advanced Symptomatic Cerebral Plaques With High Embolic Potential

Who this might be right for
Ischemic StrokeAtheroscleroses, Cerebral
Chinese University of Hong Kong 140
Not applicableLooking for participantsNCT07577609
What this trial is testing

AI-assisted CT for Risk Stratification in Coronary Artery Disease (ACTION)

Who this might be right for
Coronary Artery Disease (CAD)Computed Tomography AngiographyBiomarkers+4 more
University of Galway 10,000
Large-scale testing (Phase 3)Ended earlyNCT01417104
What this trial is testing

Aliskiren Effect on Aortic Plaque Progression

Who this might be right for
Atherosclerosis
Ohio State University 71
Not applicableStudy completedNCT01394705
What this trial is testing

FITT Exercise Counseling With Interactive Accelerometry and Physical Activity in Adolescents at Increased Risk of Early Cardiovascular Disease: A Pilot Study

Who this might be right for
Coronary Artery Disease Risk High
Boston Children's Hospital 42
Large-scale testing (Phase 3)Study completedNCT01327846
What this trial is testing

Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)

Who this might be right for
Atherosclerosis
Novartis Pharmaceuticals 10,066
Not applicableWithdrawnNCT00926055
What this trial is testing

Effects on Atherosclerosis Regression of Ezetimibe or Ezetimibe Plus Simvastatin; Evaluated by Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)

Who this might be right for
Atherosclerosis
Korea University
Next Page